 |
市場調查報告書
商品編碼
1197771
眼部整形手術市場-增長、趨勢和預測 (2023-2028)Oculoplastic Surgery Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
在預測期內，眼部整形手術市場的複合年增長率預計為 5.5%。
由於世界各地政府當局實施的預防性關閉和其他限制措施，其各自的製造和供應鏈運營中斷，全球外科手術市場受到了負面影響。 此外，由於整體經濟形勢受到大流行的嚴重影響，隨著削減非必要支出的趨勢增加，消費者需求下降。 預計上述因素將在預測期內影響全球眼科骨科市場的收入軌跡。 這可能是由於與眼睛有關的疾病、與年齡有關的眼部整形手術和技術進步的增加。 例如，2021 年 8 月，根據國家醫學圖書館的數據，造成全球眼病負擔的因素是屈光不正（2770 萬 DALY）、白內障（1770 萬 DALY）、黃斑變性（930 萬 DALY），其中包括青光眼（ 470 萬 DALYs）和沙眼（130 萬 DALYs）。 因此，眼部相關疾病的增加正在推動所研究市場的增長。
隨著老齡化社會的發展，與面部和眼瞼相關的疾病將會增加，因此市場有望增長。 例如，根據世界衛生組織 (WHO) 的數據，到 2030 年，世界上六分之一的人將超過 60 歲。 屆時，據說60歲及以上人口的比例將從2020年的10億增加到14億。
市場上的主要參與者正專注於眼科整形手術中使用的人工晶狀體和眼科整形手術設備等監管提交，這將在預測期內推動全球眼科整形手術市場的增長。預計將推動 例如，2021 年 4 月，美國眼保健產品公司博士倫公司獲得美國食品和藥物管理局 (FDA) 的批准，其 ClearVisc 是一種用於眼科整形手術的分佈式眼科粘彈性手術設備 (OVD)。 ClearVisc 含有山梨糖醇，可在白內障手術期間防止自由基。 此外，強生視力公司於 2021 年 2 月推出了 TECNIS Eyhance，這是一種單焦點人工晶狀體 (IOL)，可用於散光和非散光患者的白內障手術，散光是眼睛曲率的缺陷。Toric II 已獲得批准美國食品和藥物管理局 (FDA)。
然而，高昂的手術費用和缺乏報銷政策可能會在一定程度上阻礙市場增長。
眼科整形手術的市場趨勢
眼科整形重瞼術未來有望健康成長
隨著全球眼瞼手術數量的增加，眼瞼手術領域有望在未來實現健康發展。 例如，根據美國整形外科學會的數據，估計 2021 年全球將進行 130 萬例眼瞼手術。 雙眼皮手術，也稱為眼部拉皮術或眼瞼成形術，去除上眼瞼多餘的皮膚並減少下眼瞼的眼袋。
根據美國整形外科醫師學會的說法，眼瞼手術通常是出於美容原因。 據透露，眼瞼成形術是男性和女性最受歡迎的五種手術之一，也是 65 歲以上患者中最受歡迎的手術之一。 眼瞼成形術是一種去除眼瞼多餘皮膚的外科手術。 隨著年齡的增長，我們的眼瞼會變長，支撐眼瞼的肌肉也會變弱。 結果，多餘的皮膚和脂肪堆積在眼瞼上方和下方。 這會導致眉毛下垂、上眼瞼下垂和眼袋。 除了老化之外，眼睛周圍皮膚的嚴重下垂會降低側視（周邊視力），尤其是視野的上部和外部。 眼瞼成形術可以減少或消除這些視力問題。 此外，這種手術可以使您的眼睛看起來更年輕、更機敏。
因此，眼瞼手術的好處和老年人口的增加正在推動所研究市場的增長。
預計在預測期內北美將佔據很大的市場份額
由於人口老齡化、可支配收入增加以及願意在整容手術上花錢，預計北美將在全球眼部整形手術市場佔據重要市場份額。 根據美國骨科醫師學會的數據，2021 年美國將進行約 2300 萬次整形手術，從而推動該地區的市場發展。
意識的提高和醫療基礎設施的發展將推動該地區的市場。 眼科醫生使用激光和微型角膜刀進行 LASIK 手術，重塑眼睛的角膜以改善視力。 到 2021 年，將有大約 1200 萬美國人接受 LASIK 手術。 到 45-55 歲，老花眼的患病率在北美估計接近 80%，其中 16.5% 估計矯正不當。
全世界有 4000 萬人接受了 LASIK 手術。 在美國，超過 1000 萬美國人選擇了這種治療方法來改善他們的視力和生活質量。 據說在 2020 年，美國有 718,000 人選擇了 LASIK 手術來放棄眼鏡和隱形眼鏡。
此外，不斷增長的醫療旅遊、不斷增加的醫療支出以及成熟的醫療基礎設施也在顯著推動整個北美市場的增長。 2021 年 4 月，根據美國國家醫學圖書館的數據，許多美國患者正前往巴西、阿根廷和哥斯達黎加等拉丁美洲國家進行美容治療，在那裡他們可以經濟高效地旅行並接受先進的整容手術程序。這是可能是因為你可以使用 墨西哥是需要初級和牙科護理的美國患者的熱門旅遊目的地。
因此，上述因素正在推動該地區的市場增長。
光學整形市場競爭者分析
眼部整形手術市場競爭適中，由幾家大型企業組成。 目前主導市場的公司包括 Sklar Surgical Instruments、TEKNO-MEDICAL Optik-Chirurgie GmbH、Zimmer Biomet Holdings Inc、Integra Life Science、B. Braun Melsungen AG、Katena (Blink Medical Ltd)、Karl Storz、Bolton Surgical Ltd、Stanford Health Care , Blink 醫療有限公司等。
其他好處
- Excel 格式的市場預測 (ME) 表
- 三個月的分析師支持
內容
第一章介紹
- 研究假設和市場定義
- 調查範圍
第二章研究方法論
第 3 章執行摘要
第四章市場動態
- 市場概覽
- 市場驅動因素
- 眼睛相關疾病的增加
- 眼科整形手術隨著年齡的增長而增加
- 技術進步
- 市場製約因素
- 手術費用上漲且報銷不足
- 波特的五力分析
- 新進入者的威脅
- 買方/消費者議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第 5 章市場細分（基於價值的市場規模 - 百萬美元）
- 按手術類型
- 雙眼皮手術
- 提眉和提額
- 整容
- 小兒眼科整形外科
- 其他手術類型
- 最終用戶
- 醫院
- 門診手術中心
- 其他最終用戶
- 按地區細分
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 意大利
- 西班牙
- 其他歐洲地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東
- 海灣合作委員會
- 南非
- 其他中東地區
- 南美洲地區
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第六章競爭格局
- 公司簡介
- TEKNO-MEDICAL Optik-Chirurgie GmbH
- Zimmer Biomet Holdings Inc.
- Integra Life Science
- B. Braun Melsungen AG
- Blink Medical Ltd
- Karl Storz
- Bolton Surgical Ltd
- Stanford Health Care
- Katena（Blink Medical Ltd）
第7章 市場機會今後動向
The oculoplastic surgery market is expected to register a CAGR of 5.5% during the forecast period.
Surgery markets across the world have been negatively impacted due to the disruptions experienced by their respective manufacturing and supply-chain operations as a result of precautionary lockdowns and other restrictions enforced by governing authorities across the globe. Moreover, consumer demand has also subsequently reduced as individuals are now more keen on eliminating non-essential expenses from their respective budgets as the general economic status of most people has been severely affected by the pandemic. The aforementioned factors are expected to burden the revenue trajectory of the global oculoplastic surgery market during the forecast period. This may be attributed to the increasing number of eye-related disorders, age-related oculoplastic surgeries, and technological advancements. For instance, in August 2021, as per the National Library of Medicine, contributors to the burden of eye disease at the global level are refractive errors (27.7 million DALYs), cataracts (17.7 million DALYs), macular degeneration (9.3 million DALYs), glaucoma (4.7 million DALYs), trachoma (1.3 million DALYs), etc. Thus, the increasing number of eye-related disorders is driving the growth of the market studied.
With the growing aging population, there would be an increase in disorders related to the face and eyelids, resulting in the market's growth. For instance, according to the World Health Organization, by 2030, one in six people in the world will be aged 60 years and above. At this time, the share of the population aged 60 years and above will increase from 1 billion in 2020 to 1.4 billion.
Key players operating in the market are focusing on submitting applications for the approval of intraocular lenses, oculoplastic surgery devices, etc., for use in ocular surgery, which is expected to drive the growth of the global oculoplastic surgery market over the forecast period. For instance, in April 2021, Bausch & Lomb Incorporated, a US-based eye health products company, received the United States Food and Drug Administration (FDA) approval for ClearVisc, a dispersive ophthalmic viscosurgical device (OVD) to be used in ocular surgery. ClearVisc contains sorbitol which protects from free radicals during cataract surgery. Moreover, in February 2021, Johnson & Johnson Vision announced that it received the United States Food and Drug Administration (FDA) approval for its TECNIS Eyhance Toric II monofocal intraocular lens (IOL) that can be used in cataract surgery of patients with or without astigmatism, an imperfection in the curvature of the eye.
However, the high cost of surgeries and lack of reimbursement policies may hamper the growth of the market to a certain extent.
Oculoplastic Surgery Market Trends
Eyelid Surgery in Oculoplastic Surgery is Expected to Witness a Healthy Growth in Future
The eyelid surgeries segment is expected to witness healthy growth in the future, attributed to the growing number of eyelid surgeries worldwide. For instance, as per the American Society of Plastic Surgeons, an estimated 1.3 million eyelid procedures were carried out globally in 2021. Eyelid surgeries are also called eyelifts and blepharoplasty, where an excess of skin is removed from the upper eyelid and reduces bagginess from the lower eyelid.
As per the American Society of Plastic Surgeons, eyelid surgery is often performed for cosmetic reasons. The source also revealed that blepharoplasty was one of the five most popular procedures among both men and women and the single most popular procedure among patients aged 65 and older. Blepharoplasty removes excess skin from the eyelids. With age, eyelids stretch, and the muscles supporting them weaken. As a result, excess skin and fat can gather above and below the eyelids. This can cause sagging eyebrows, droopy upper lids, and bags under the eyes. Besides aging, severely sagging skin around the eyes can reduce side vision (peripheral vision), especially the upper and outer parts of the visual field. Blepharoplasty can reduce or get rid of these vision problems. The surgery can also make the eyes look younger and more alert.
Thus, the advantages of eyelid surgery and the growing geriatric population are driving the growth of the market studied.
North America is Expected to Hold a Significant Share in the Market During the Forecast Period
North America is expected to hold a significant market share in the global oculoplastic surgery market due to the increasing aging population, rising disposable income, and willingness to spend on aesthetic surgeries. As per the American Society of Plastic Surgeons, in 2021, around 23 million plastic surgery procedures were performed in the United States, leading to a boost in the market in this region.
Rising awareness levels and developed healthcare infrastructure would raise the market in this region. An ophthalmologist performs LASIK surgery using a laser or microkeratome to reshape the eye's cornea and improve visual acuity. As of 2021, roughly 12 million Americans had LASIK. The prevalence of presbyopia was estimated at nearly 80% by ages 45-55 in North America, with an estimated 16.5% of these individuals without adequate correction.
Forty million people around the globe had LASIK surgery. In the United States, over ten million Americans have chosen to improve their vision and their quality of life with this treatment. In 2020, 718,000 people in the United States opted for LASIK surgery to ditch their eyeglasses or contacts.
Moreover, growing medical tourism, increasing healthcare expenditure, and the presence of well-established healthcare infrastructure are also greatly fueling the overall growth of the market in North America. In April 2021, as per the national library of medicine, many American patients visited South or Central American countries like Brazil, Argentina, or Costa Rica for cosmetic treatment, as they can travel cost-effectively and avail themselves of advanced cosmetic surgery. Mexico is a popular destination for American patients who need primary and dental care.
Thus, the aforementioned factors are boosting the growth of the market in the region.
Oculoplastic Surgery Market Competitor Analysis
The oculoplastic surgery market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Sklar Surgical Instruments, TEKNO-MEDICAL Optik-Chirurgie GmbH, Zimmer Biomet Holdings Inc., Integra Life Science, B. Braun Melsungen AG, Katena (Blink Medical Ltd), Karl Storz, Bolton Surgical Ltd, Stanford Health Care, and Blink Medical Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Increasing Number of Eye Related Disorder
- 4.2.2 Growing Number of Age-Related Oculoplastic Surgeries
- 4.2.3 Technological Advancement
- 4.3 Market Restraints
- 4.3.1 High Cost of Surgeries and Lack of Reimbursement
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Procedure Type
- 5.1.1 Eyelid Surgery
- 5.1.2 Brow Lift and Forehead Lift
- 5.1.3 Facelift
- 5.1.4 Pediatric Oculoplastic surgery
- 5.1.5 Other Procedure Types
- 5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Ambulatory Surgical Centers
- 5.2.3 Other End Users
- 5.3 By Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 TEKNO-MEDICAL Optik-Chirurgie GmbH
- 6.1.2 Zimmer Biomet Holdings Inc.
- 6.1.3 Integra Life Science
- 6.1.4 B. Braun Melsungen AG
- 6.1.5 Blink Medical Ltd
- 6.1.6 Karl Storz
- 6.1.7 Bolton Surgical Ltd
- 6.1.8 Stanford Health Care
- 6.1.9 Katena (Blink Medical Ltd)
